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Abstract 
Skeletal muscle, cartilage and bone must function in a co-ordinated fashion during locomotion and 
growth. In the present study on the gilthead sea bream (Sparus aurata) we tested the hypothesis that 
muscle and bone differ in their responsiveness to stimuli eliciting fast growth, providing a potential 
mechanism for generating the skeletal deformities observed in aquaculture. To investigate transcription 
regulation in skeletal muscle and bone we stimulated protein synthesis using a flooding dose of the 
branched chain amino acid leucine and compared the results with saline-injected controls. To increase 
the amount of available sequence information for gene expression analysis a de novo transcriptome 
was assembled using publicly available Next Generation Sequencing libraries from embryo, fast 
skeletal muscle, bone and cartilage. The resulting 5 million reads were assembled into 125,646 isotigs 
representing around 16,000 unique genes, including most components of the Pi3k/Akt/mTor signalling 
pathway. Principal Components Analysis was able to distinguish the transcriptional responses between 
leucine and saline injected controls in skeletal muscle, but not in bone. General Linear Modelling 
revealed significant temporal changes in gene expression following leucine injection including the 
tissue-specific markers sparc, bglap (bone), mlc2 and myod2 (muscle) and gene transcripts associated 
with Pi3k/Akt/mTor signalling, p70sk6, akt2, ampka and mtor. Skeletal muscle showed more 
pronounced and rapid changes in transcript abundance than bone to the same pro-growth signal. The 
observed differences in transcriptional response are consistent with the idea that fast growth results in a 
miss-match between muscle and bone development and may contribute to a higher incidence of 
skeletal deformities. 
 
Keywords: NGS, muscle, bone, expression, Leucine, mTOR, fast growth, aquaculture, skeletal 
deformities. 
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1. Introduction 
Bone, cartilage and skeletal muscle are the three main components of the musculoskeletal system. The 
bones give “stability” to the fish body, permit movement, provide physical protection to some organs 
and have a central role in Ca
+2
 storage and ionic homeostasis (Guerreiro et al., 2007). The trunk muscle 
is segmented and arranged in myomeres (Altringham and Ellerby, 1999) transmitting contractile force 
via tendons, to the axial skeleton, resulting in the bending of the fish body and propulsion (Altringham 
and Ellerby, 1999). Cartilage has a more static function, it forms the new framework for endochondrial 
bone with a high turnover (eg. fin rays), provides elasticity to the fish skeleton and is involved in a 
variety of functions including locomotion (Symmons, 1979; Benjamin et al., 1992).   
During growth increasing muscle mass needs to be coordinated with bone formation and 
mineralization. A mismatch in growth rates between tissues could theoretically result in a poorly 
mineralized bone attempting to support the increasing force generated by muscle, leading to the 
development of bone deformities (Lysfjord et al., 2002). Such deformities directly affect muscle 
structure, swimming performance and, ultimately, have an impact on fish growth and welfare (Waagbø 
et al., 2005). For example, mineralization problems in farmed Atlantic salmon (Salmo salar) were 
observed to increase during smoltification with adverse impacts on fish welfare (Fjelldal et al., 2006).   
The gilthead sea bream (Sparus aurata) is a member of the Sparidae family and is intensively farmed in 
Southern European countries with an annual production of 120,000 metric tonnes (FAO, 2008). Bone 
deformities have a significant impact on gilthead sea bream production, with nearly 80% of fry and 
juveniles affected (Andrades et al., 1996; Boglione et al., 2001; Boglione et al., 2013). Various types of 
skeletal deformities have been described, including an incomplete jaw, open operculum, abnormal 
caudal fin and deformities in the 2
nd
 and 6
th
 vertebrae of the backbone (Moretti et al., 1999; Boglione et 
al., 2001; Boglione et al., 2013).  
Branched chain amino acids, particularly leucine, are powerful stimulators of protein synthesis in 
mammals (Anthony et al., 2001) and fish (Kawango et al., 2015; Ren et al., 2015), and suppress protein 
breakdown in humans (Louard et al., 1995). Pi3k/Akt/mTor signalling is the main pathway regulating 
protein synthesis during muscle growth in fish (Seiliez et al., 2008; Johnston et al., 2011; Garcia de la 
serrana et al., 2012a). Recent studies in mammals have also identified the Pi3k/Akt/mTor pathway as 
an important promoter of growth and development in bone (Xian et al., 2012) with key roles in 
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chondrocytes (Phornphutkul et al., 2008) and osteoblasts (Sun et al., 2013) in response to pro-growth 
signals such as leucine (Kim et al., 2009). 
The first objective of the present study was to increase the available nucleotide sequence resources for 
gene expression studies in gilthead sea bream by generating a de novo assembly using publicly 
available EST and 454-Next Generation Sequencing (NGS) data from embryos, bone, cartilage and fast 
skeletal muscle (Garcia de la serrana et al., 2012b; Florbela et al., 2013; Calduch-Giner et al., 2013). 
Phylogenetic analyses enabled paralogues associated with the teleost-specific whole genome 
duplication to be identified and specific primers developed to study the transcriptional regulation of 
bone and muscle growth markers and components from the Pi3k/Akt/mTor and associated signalling 
pathways. In order to further investigate the bone-muscle growth miss-match hypothesis of skeletal 
deformities gene expression signatures were compared over time in groups of fish injected with either 
saline or a flooding dose of the branched chain amino acid leucine.  
 
 
2. Material and methods 
2.1. Gilthead sea bream de novo transcriptome and bioinformatic analyses 
Publicly available 454 Titanium-libraries for skeletal muscle (ERP000874), bone, cartilage 
(ERP002185), embryo (SRX076735) and all ESTs available for gilthead sea bream (Sparus aurata) 
were retrieved from NCBI Short Reads Archive (www.ncbi.nlm.nih.gov/sra) (October 2013). Isotigs 
were constructed using Newbler 2.5 assembler (Roche, 454 Life Sciences) in a Debain Linux system, 
IBM x3755 8877, with 8 CPU cores (4 x dual-core AMD Opteron), 64-bit, 2.8 GHz processor with 128 
Gb of RAM maintained by the University of St Andrews. Isotig identification, gene ontology 
annotation, pathway mapping by KEGG Automatic Annotation Server (KAAS) 
(http://www.genome.jp/tools/kaas/), full-length coding sequences (CDS) and paralogue detection were 
performed as previously described (Garcia de la serrana et al., 2012b). Phylogenetic analysis for 
paralogue identification and nomenclature were performed as previously described (Garcia de la 
serrana et al., 2012b). 
 
2.2. Digital gene expression analysis 
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The 454-libraries from juvenile gilthead sea bream skeletal muscle, bone and cartilage were generated 
from the same animals enabling a direct comparison of transcript abundance between tissues. Reads 
used from bone, cartilage and skeletal muscle libraries were separately mapped against the gilthead sea 
bream de novo transcriptome using GS Reference Mapper (Roche, 454 Life Sciences). Differences in 
number of reads mapped from each tissue were analysed using R-based script as previously described 
(Garcia de la serrana et al., 2012b).  
 
2.3. Leucine and control injections and sampling 
120 gilthead sea bream juveniles of 108.0 ± 0.8g body mass and 17.7 ± 0.04cm fork length (Mean ± 
SE) were maintained in the CCMAR Ramalhete field station in Faro, Portugal. Animals were 
distributed between 6 individual 200L fibreglass tanks (30 animals per tank) in an oxygenated, open 
circuit seawater system and maintained at 24.8 ± 0.2
o
C at constant salinity (36 ± 0.3ppt) in duplicated 
experiments. Fish were fasted overnight (16h) and anesthetized with tricaine methane sulfonate-MS222 
(20mg/l, SIGMA, Dorset, UK) and given a single intraperitoneal injection of 1ml solution containing 
150mM (177mg/kg body mass) leucine (leu) (SIGMA) or a saline control, pH 7.4 as previously 
described in Owen et al., 1999 for salmon. Individuals from both treatments were injected in parallel in 
groups of 5 at intervals of 20 minutes. Fish were sacrificed before the treatment (0h) and at 1h, 3h, 7h, 
12h and 24h post-injection using an overdose of tricaine methane sulfonate-MS222 (50mg/l) (SIGMA) 
followed by sectioning of the spinal cord. Fast skeletal muscle at 0.5 fork length and a clean section of 
the backbone were rapidly dissected, flash frozen in liquid nitrogen and stored at -80
o
C until further 
analysis. 
 
2.4. Ethical statement 
All animal experiments were carried out in compliance with the Guidelines of the European Union 
Council (86/609/EU) and Portuguese legislation for the use of laboratory animals. All animal protocols 
were performed under a Group-1 license from the Direcção-Geral de Veterinaria, Ministerio da 
Agricultura, do Desenvolvimento Rural e das Pescas. 
 
2.5. Quantitative real-time PCR 
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Total RNA and cDNA synthesis from individual bone and skeletal muscle samples were performed as 
previously described (Garcia de la serrana et al., 2012a). The qPCR procedures were compliant with 
the minimal information requirements for publication of quantitative PCR guidelines (Bustin et al. 
2009). Primers were designed with Net primer (www.premierbiosoft.com/netprimer/) with melting 
temperatures of 60
o
C, and where possible crossed an exon-exon junction. Sequences for ribosomal 
protein S6 kinase 1 (p70sk6), 5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha 
(ampka) and mechanistic target of rapamycin serine/threonine-protein kinase (mtor) were retrieved 
from the de novo gilthead sea bream transcriptome (sequences retrieved are summarized in 
Supplementary File 1) while other primers were design based on public sequences (Supplementary File 
2). Primers sequences, amplicon size, efficiency and melting temperature for qPCR are listed in 
Supplementary File 2. All qPCR reactions, primer pair efficiency estimation and controls were 
performed as previously described (Garcia de la serrana et al., 2012a). The stability of four reference 
genes r18, β-actin, elongation factor 1 alpha (ef1α) and ribosomal protein L27 (rpl27) (Supplementary 
File 2) was tested using Bestkeeper software (Michael et al. 2004). Analysis demonstrated that ef1a 
was the most stable reference gene across tissues and time points and was selected to calculate the 
relative expression of each gene using the Pfaffl method (Pfaffl,  2001).  
 
2.6. Statistical Analysis 
Statistical analysis of qPCR results was performed using PASW Statistics 21.0 for Mac (IBM). Gene 
expression was analysed using principal components analysis (PCA) and a general linear model with 
treatment as the variable, tissue and time as cofactors and fish length as a random factor. The number 
of reads mapped from each condition was extracted using the R statistical package (www.R-
project.org) and Chi-square statistic followed by a Hochberg-Benjamin (false discovery rate, FDR) 
correction was applied to detect significant differences in the number of reads per isotig as previously 
described (Garcia de la serrana et al., 2012b). Graphs comparing the contribution of reads from each 
experimental condition per isotig were constructed using R-script as previously described (Garcia de la 
serrana et al., 2012b).  
 
3. Results 
3.1. De novo assembly 
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Over 5 million reads were assembled into 125,646 isotigs with an average length of 725bp 
(N50=1073bp). Around 50,000 isotigs were successfully annotated, containing over 16,000 unique 
genes (Supplementary File 3), equivalent to the 62 to 83% of the protein-coding genes described for 
other teleost species (www.ensembl.org). Comparison of zebrafish complete proteome against the 
gilthead sea bream transcriptome allowed us to identify over 4,000 different isotigs containing more 
than 90% of the coding sequence (Supplementary File 3). A total of 180 paralogue pairs were identified 
in the gilthead sea bream transcriptome using phylogenetic analyses and named according to the 
zebrafish nomenclature, significantly increasing the number identified for this species (Garcia de la 
serrana et al., 2012b; Supplementary File 3). 
 
3.2. Skeletal muscle, bone and cartilage digital gene expression  
In order to study the major differences in digital gene expression (DGE) between fast skeletal muscle, 
bone and cartilage reads were mapped against the global transcriptome and normalized by isotig length 
and library size. Pairwise comparisons of reads mapped were used to infer differential DGE between 
tissues (Fig. 1).  
The top 10 isotigs appearing in the ranked list of the most differently expressed genes between tissues 
are shown in Table 1 (the complete list can be found in Supplementary File 4). Gene Ontology (GO) 
analysis of all genes that showed significant differences in expression in fast skeletal muscle 
(Supplementary File 5) revealed enriched in genes categories related to “muscle contraction” 
(GO:0006936), “ribosomal subunit” (GO:0044391), “sarcomere” (GO:0030017) and 
“gluconeogenesis” (GO:0006094). In contrast, categories such as “intermediate filament cytoskeleton 
organization” (GO:0045104), “neurofilament” (GO:0005883), “structural molecular activity” 
(GO:0005198) and synapse (GO:0045202) were enriched in bone and “electron transport chain” 
(GO:0022900), “secretion” (GO:0046903), “respiratory chain” (GO:0070469) and “fibrillar collagen” 
(GO:0005583) were enriched in cartilage (Supplementary File 5).  
 
3.3. Effects of a flooding dose of leucine on gene expression  
Gilthead sea bream were injected with a flooding dose of leucine or a saline control to study the 
response at transcriptional level in bone and muscle for key components or the Pi3k/Akt/mTor and 
associated signalling pathways including akt2, ampka, mtor and p70sk6. Tissue-specific genes for 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 8 
skeletal muscle (myod2, mlc2) and bone (bglap, sparc) plus col1a were also included in the analysis. 
Principal components analysis (PCA) was used to initially explore the data and establish whether the 
observed differences in genes expression could be attributed to treatments and/or tissues. Our PCA 
analysis clearly separated gene expression signatures from the different tissues (Fig. 2A), driven by the 
influence of the tissue-specific genes (Fig. 2B). PCA analysis also distinguished between leucine 
injected and control individuals for skeletal muscle, but for bone (Fig. 2A), consistent with a more 
pronounced impact on transcription in skeletal muscle. General linear modelling demonstrated that 
leucine injection significantly changed the expression of all Pi3k/Akt/mTor components measured 
(mtor, akt2 and p70sk6) (Fig. 3; Table 2). The expression of ampka, a gene with a central role in 
regulating energy metabolism, showed no clear pattern following leucine injection (Table 2; 
Supplementary File 6). Skeletal muscle gene markers myod2 and mlc2 were expressed at very low 
levels or were absent in bone tissue (Fig. 4). Myod2 is a member of the myogenic regulatory factor 
family of transcription factors involved in the activation of myoblasts and initiation of the myogenesis 
program (Review in Fong and Tapscott, 2014 and Johnston, 2006) while mlc2 is a contractile protein 
(reviewed in Scruggs and Solaro, 2011). Mlc2 and myod2 significantly increased expression in 
response to leucine injection with a rapid recovery of mlc2 to pre-injection values, but a sustained 
elevation of myod2 (Fig. 4; Table 2). Sparc is secreted by osteoblasts during bone formation, initiates 
mineralization and form complexes with collagen (Jundt et al., 1987; Yan and Sage, 1999). Bglap is 
only secreted by osteblasts and plays a crucial role in bone matrix formation representing up to 1-2% of 
the total bone protein with a strong affinity for calcium (Lee et al., 2007). Sparc and bglap genes were 
detected in bone, but not in skeletal muscle, and col1a was present in both tissues (Fig. 5; Table 2; 
Supplementary File 6). Expression of sparc and bglap were significantly affected by leucine injection 
(Table 2; Figure 5), although considerable variability was observed between individuals. The detection 
of col1a in skeletal muscle could be explained by the presence of tendons and the connective sheet 
surrounding muscle fibres, where col1a is an important component (Supplementary File 6). There were 
significant changes in transcript abundance for Pi3k/Akt/mTor components after only 1h in skeletal 
muscle but not until 3-7h after injection in bone, consistent with differences in the sensitivities of the 
tissues to a pro-growth stimulus (Fig. 3).  
 
4. Discussion 
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The gilthead sea bream de novo transcriptome described here significantly improves on previous 
transcriptomes in terms of the number of isotigs annotated (>50,000), and number of unique genes 
identified (>16,000) including near full-length transcripts (2,981 with >90% of CDS) (Garcia de la 
serrana et al., 2012b). The number of paralogues retained from the teleost-specific whole genome 
duplication is around 20% of gene content (Garcia de la serrana et al., 2014) whereas we could only 
identify 360 from this 454 assembly equivalent to 24% of the expected number and much less than 
estimates in some other fish species using the Illumina platform (Mareco et al., 2015). 
The DGE analysis was able to capture basic differences between tissues (Fig. 1, Table 1; Files S4 and 
S5). Skeletal muscle showed a significant enrichment of muscle-specific genes including sarcomere 
structural components such as mlc2 or myosin heavy chain (mhc) (Clark et al., 2002) and myogenic 
regulators such as myostatin (Johnston, 2006) together with an enrichment in genes related to 
“gluconeogenesis”, e.g. aldolase and phosphoglucomutase, reflecting the predominant glucose-based 
metabolism in fast skeletal muscle (Izumiya et al. 2008). Bone and cartilage DGE and GO analyses 
were also consistent with the main physiological roles of these tissues, particularly genes related to 
secretion, collagen and production of extracellular matrix (Estêvão et al., 2011) (Table1; 
Supplementary File 4 and 5). However, there was a significant presence of genes related to 
neurofilaments in the bone libraries and “oxidation-reduction processes” in the cartilage libraries, a 
strongly anaerobic tissue (Grimshaw and Manson, 2004) suggesting that neural cord and gills were not 
totally removed during dissection of bone and cartilage samples, respectively.  
Previous studies in mammals have already demonstrated the importance of Pi3k/Akt/mTor pathway in 
bone growth and matrix development (Xian et al., 2012), but this remains unexplored in fish. Our 
results show that key components of the Pi3k/Akt/mTor pathway are stimulated in bone and skeletal 
muscle in response to leucine injection, consistent with an increase in protein synthesis.  Downstream 
genes associated with growth in muscle (myod2 and mcl2) and bone (sparc and bglap) were similarly 
more highly expressed in leucine-injected than saline-injected controls. 
The main finding of the present study was that transcripts showed a faster and more pronounced 
response to leucine injection in skeletal muscle than bone for the majority of genes analysed (Fig. 2). 
The reasons behind the distinct time courses of transcriptional responses in bone and muscle are 
unknown, but could include differences in the dynamics of leucine uptake, amino acid sensing and 
other regulatory processes. GO terms related to “translational elongation” and “ribosomal subunit” 
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(Supplementary File 4) were significantly enriched in skeletal muscle compare to bone in our 
transcriptome, indicating a greater capacity for protein synthesis in the former tissue. Skeletal muscle 
in fish has a well-known function as a reservoir of amino acids which are seasonally mobilised for 
migration and to build gonads prior to spawning (Mommsen et al., 1980). This function together with a 
higher capacity for protein synthesis may also underlie the faster and more pronounced transcriptional 
response to pro-growth signals in muscle than bone. Bone marrow has a role in regulating bone growth 
by contributing monocyte-macrophage cells to the osteoclast population, by stimulating 
osteoclastogenesis and through secretion of IL-11 (Usha and Nandeesh, 2000). Bone marrow is also a 
primary source of Igf1, one of the key regulators of the Pi3k/Akt/mTor pathway (Xian et al., 2012). 
 Igf1 receptors in fish muscle stimulate amino acid uptake (Degger et al., 2000), leading to myoblast 
proliferation and DNA synthesis (Pozios et al., 2005; Duan et al., 2010). Igf1 provokes a rapid 
proliferative response in sea bream myoblasts in culture within 24h – 36h of treatment (Castillo et al., 
2002). It has been suggested that in bone where growth is regulated through the growth hormone 
receptor in salmon vertebrae whereas the Igf1 receptor is more involved with mineralisation (Wargelius 
et al., 2005).  Furthermore, in vitro experiments with sea bream osteocytes found that proliferative 
responses to Gh and Igf1 treatment were relatively slow and only observed after 5 d (Capilla et al., 
2003).   
Differential responses to powerful pro-growth signals at the transcriptional, protein signalling and 
cellular levels provide a potential mechanism for the hypothesised mismatch between the growth of 
muscle and bone under conditions of fast growth in all stages of the life cycle (Boglione et al., 2013; 
Lysfjord et al., 2002; Lewis et al., 2004; Wargelius et al., 2009) and likely contribute to the high 
incidence of skeletal deformities observed in aquaculture for this species.   
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Table 1. 
Top 10 differentially expressed genes in number of mapped reads between bone, cartilage and fast 
skeletal muscle. 
Tissue Gene ID Length 
(bp) 
Muscle 
(reads) 
Bone 
(reads) 
Cartilage 
(reads) 
FDR Orthologue 
ID 
        
Muscle Glycogen synthase 589 6372 64 220 0.0054 gys1 
 Myosin Light Chain 2 598 5896 43 34 0.0064 mlc2 
 Myosin heavy chain 866 5561 52 18 0.0109 * 
 Fructose-
bisphosphate 
aldolase a 
599 5477 56 23 0.0237 aldoa 
 Phosphoglucomutase 
1 
301 3803 12 53 0.0057 pgm1 
 Lysophosphatidylchol
ine acyltransferase 1 
183 3376 0 0 0.000 lpcat1 
 Sarcoplasmic 
endoplasmic 
reticulum calcium 
atpase 1 
352 2991 21 37 0.032 atp2a1 
 solute carrier family 
25 member a5 
317 2496 21 14 0.00041 slc25a5 
 Glycerol-3-phosphate 
dehydrogenase 
221 2028 6 2 0.0012 gpd1 
 Hemoglobin subunit 
alpha-2 
269 1936 22 64 0.010 hba2 
        
Bone Vimentin 2188 0 509 0 0.000 vim 
 Rab gdp dissociation 
inhibitor alpha 
3292 0 291 8 0.000 gdi1 
 Neurofilament-
medium polypeptide 
1214 0 226 0 0.000 nefm 
 Asporin 2523 0 222 10 0.0108 aspn 
 Stathmin 1771 0 216 2 0 stmn1 
 Ubiquitin carboxyl-
terminal hydrolase 
isozyme l1 
1389 0 194 2 0 uchl1 
 Complexin 1 2039 0 190 0 0 cplx1 
 Probable g-protein 
coupled receptor 132 
700 
 
0 177 4 0 gpr132 
 Synaptosomal-
associated protein 25 
2127 0 175 0 0 snap25 
 Peripherin 1117 0 175 0 0 prdh 
        
Cartilage nadh dehydrogenase 
subunit 1 
284 212 429 3396 0.0002 mt-nd1 
 nadh dehydrogenase 516 108 129 3218 0.007 mt-nd5 
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subunit 5 
 cytochrome c oxidase 
subunit iii 
177 34 103 2481 0.000 mt-co3 
 nadh dehydrogenase 
subunit 4 
266 87 23 2327 0.0004 mt-nd4 
 nadh dehydrogenase 
subunit 6 
252 61 89 1461 0.011 mt-nd6 
 Tenascin isoform 1 3381 0 2 671 0.000 tnxb 
 Coagulation factor 
xiii 
4670 0 2 573 0.000 f13a1 
 Calcium-binding 
tyrosine 
605 0 17 440 0.000 cabyr 
 Cartilage matrix 
protein 
2497 0 42 385 0.000 crtap 
 Calcium-binding 
phosphoprotein 5 
precursor 
925 0 8 346 0.000 notch1 
        
Gene ID and orthologue name were obtained by blastx against the NCBI nr database. FDR: False 
Discovery Rate. 
* The specific isoform of the myosin heavy chain was not identified with a high enough degree of 
confidence. 
 
Table 2.  
Statistical analysis of gene expression in response to leucine or saline injection. P-values for time, 
tissue, treatment factors and tissue*treatment interaction are shown.  
 Gene ID Time Tissue Treatment Tissue *Treatment 
Pi3k/Akt/mTor akt2 0.45 0.00 0.00 0.01 
 mtor 0.12 0.00 0.00 0.01 
 p70sk6 0.02 0.67 0.00 0.01 
 ampka 0.05 0.63 0.01 0.01 
Muscle markers myod2 0.35 0.00 0.00 0.27 
 mlc2 0.31 0.00 0.04 0.02 
Bone markers col1a 0.74 0.04 0.18 0.20 
 bglap 0.21 0.00 0.00 0.21 
 sparc 0.25 0.00 0.00 0.25 
 
Ribosomal protein S6 kinase 1 (p70sk6), RAC-beta serine/threonine-protein kinase (akt2), osteonectin 
(sparc), osteocalcin (bglap), myosin light chain 2 (mlc2), myoblast determination protein 2 (myod2), 
5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha (ampka), mechanistic target of 
rapamycin serine/threonine-protein kinase (mtor) and Collagen alpha-1(I) chain (col1a). 
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Figures legends 
Fig. 1. Dot plot pairwise comparison of reads mapped from each tissue to the annotated isotigs. Each 
dot represents an isotig with reads from one or both tissues. X and Y graph illustrates the relative 
abundance of reads from each tissue mapped per isotig. 
 
Fig. 2. (A) Principal component analysis using the expression of all genes analysed in bone (empty 
circles for controls and empty diamonds for leucine) and skeletal muscle (full circles for controls and 
full diamonds for leucine). Dashed ellipse include >80% of the skeletal muscle control samples; 
continuous ellipse include >80% of the leucine injected skeletal muscle samples (B) Relative weight 
contribution of each of the genes analysed in the generation of the two PCA components during the 
principal components analysis and the percentage of variability explained by each of the components. 
Genes part of the Pi3k/Akt/mTor pathway are indicated in dark grey background, skeletal muscle gene 
markers are indicated in pale grey background and bone gene markers are indicated in white 
background. Ribosomal protein S6 kinase 1 (p70sk6), RAC-beta serine/threonine-protein kinase (akt2), 
osteonectin (sparc), osteocalcin (bglap), myosin light chain 2 (mlc2), myoblast determination protein 2 
(myod2), 5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha (ampka), 
mechanistic target of rapamycin serine/threonine-protein kinase (mtor) and collagen alpha-1(I) chain 
(col1a)   
 
Fig. 3. Gene expression of Pi3k/Akt/mTor components in response to intra-peritoneal injection of 
leucine in bone and skeletal muscle. Gene expression values are expressed as arbitrary units (a.u) for 
RAC-beta serine/threonine-protein kinase (akt2) (A), mechanistic target of rapamycin serine/threonine-
protein kinase (mtor) (B) and ribosomal protein S6 kinase 1 (p70sk6) (C) in response to leucine (filled 
symbols) or saline (open symbols) for bone (circles) and skeletal muscle (squares). Values represent 
mean ± SE (N=10 fish per time point for each treatment). 
 
Fig. 4. Gene expressions of skeletal muscle gene markers in response to intra-peritoneal injection of 
leucine in bone and skeletal muscle. Gene expression values are expressed as arbitrary units (a.u) for 
myoblast determination protein 2 (myod2) (A) and myosin light chain 2 (mlc2) (B) in response to 
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leucine (filled symbols) or saline (open symbols) for bone (circles) and skeletal muscle (squares). 
Values represent mean ± SE (N=10 fish per time point for each treatment). 
 
Fig. 5. Gene expressions of skeletal muscle gene markers in response to intra-peritoneal injection of 
leucine in bone and skeletal muscle. Gene expression values are expressed as arbitrary units (a.u) for 
osteonectin (sparc) (A) and osteocalcin (bglap) (B) in response to leucine (filled symbols) or saline 
(open symbols) for bone (circles) and skeletal muscle (squares). Values represent mean ± SE (N=10 
fish per time point for each treatment). 
 
 
 
 
 
Supplementary Files 
Supplementary File 1. Mechanistic target of rapamycin serine/threonine-protein kinase (mtor), 
ribosomal protein S6 kinase 1 (p70sk6) and 5'-AMP-activated serine/threonine-protein kinase catalytic 
subunit alpha (ampka) extracted from the de novo gilthead sea bream transcriptome used for primer 
design.  
Supplementary File 2. Primers sequences used for quantitative PCR amplification. E=efficiency, 
Tm=melting temperature. Ribosomal protein S6 kinase 1 (p70sk6), RAC-beta serine/threonine-protein 
kinase (akt2), osteonectin (sparc), osteocalcin (bglap), myosin light chain 2 (mlc2), myoblast 
determination protein 2 (myod2), 5'-AMP-activated serine/threonine-protein kinase catalytic subunit 
alpha (ampka), mechanistic target of rapamycin serine/threonine-protein kinase (mtor), collagen alpha-
1(I) chain (col1a), s18, beta actin (β-actin), elongation factor 1 alpha (ef1α) and ribosomal protein L27 
(rpl27). 
Supplementary File 3. Compressed file containing transcriptome BLAST results, list of unique genes 
found and phylogenetic trees of paralogues identified in the de novo transcriptome. 
Supplementary File 4. Complete list of genes differentially expressed in muscle, bone and cartilage. 
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Supplementary File 5. Gene Ontology analysis of differently expressed genes in muscle, bone and 
cartilage. 
Supplementary File 6. Gene expressions of skeletal muscle gene markers in response to intra-
peritoneal injection of leucine in bone and skeletal muscle. Gene expression values are expressed as 
arbitrary units (a.u) for 5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha 
(ampka) (A) and collagen alpha-1(I) chain (col1a) (B) in response to leucine (filled symbols) or saline 
(open symbols) for bone (circles) and skeletal muscle (squares). Values represent mean ± SE (N=10 
fish per time point for each treatment). 
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